# Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease

> **NCT05295355** · NA · UNKNOWN · sponsor: **Guangzhou Institute of Respiratory Disease** · enrollment: 72 (estimated)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Tiotropium Bromide Combined With Odaterol

## Key facts

- **NCT ID:** NCT05295355
- **Lead sponsor:** Guangzhou Institute of Respiratory Disease
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-01-25
- **Primary completion:** 2024-09
- **Final completion:** 2025-03
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2022-10-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05295355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05295355, "Effect of Tiotropium Bromide Combined With Odaterol on Small Airway Remodeling in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05295355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*